Trenaxa Tablet 1*10

1. **Management of Menstrual Disorders**: Similar to Trenaxa 500 tablets, Trenaxa MF tablets are commonly prescribed to manage heavy menstrual bleeding (menorrhagia) in women. Tranexamic acid helps reduce menstrual blood loss by stabilizing blood clots, while mefenamic acid provides pain relief by reducing prostaglandin production, which is associated with menstrual cramps.

2. **Reduction of Menstrual Pain**: Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), helps alleviate menstrual pain (dysmenorrhea) by reducing inflammation and prostaglandin levels in the uterus. This can lead to a decrease in the intensity and duration of menstrual cramps.

3. **Combined Therapeutic Effects**: By combining tranexamic acid and mefenamic acid in a single tablet, Trenaxa MF provides both hemostatic (bleeding reduction) and analgesic (pain relief) effects, offering comprehensive management of heavy menstrual bleeding and associated pain.

4. **Prevention of Blood Clots**: Tranexamic acid in Trenaxa MF tablets works by inhibiting the breakdown of blood clots, thereby preventing excessive bleeding during menstruation. This can help reduce the need for blood transfusions and minimize the impact of heavy menstrual bleeding on daily activities.

5. **Convenient Dosage Form**: Trenaxa MF tablets offer a convenient and practical treatment option for women experiencing heavy menstrual bleeding and menstrual pain. The combination formulation simplifies the medication regimen, potentially improving patient compliance with treatment.

6. **Reduction of Anemia Risk**: By effectively controlling heavy menstrual bleeding, Trenaxa MF tablets can help reduce the risk of iron-deficiency anemia, which can occur due to chronic blood loss during menstruation.

7. **Short-Term Use for Menstrual Disorders**: Trenaxa MF tablets are typically used for short-term treatment during menstrual periods to alleviate symptoms of heavy bleeding and menstrual pain. However, the duration of treatment may vary depending on the individual’s condition and response to therapy.